PPARg Modulators and Methods of Use
Summary
USPTO granted Patent US12606541B2 to Eisai R&D Management Co., Ltd. on April 21, 2026. The patent covers 34 claims for PPARg modulators (compounds of Formula 1) and their methods of use, including pharmaceutical compositions containing these compounds. The patent was filed November 8, 2021, with application number 17521666.
What changed
USPTO issued Patent US12606541B2 to Eisai R&D Management Co., Ltd. covering novel PPARg (peroxisome proliferator-activated receptor gamma) modulator compounds of Formula 1 and their pharmaceutical salts, along with compositions and methods of use. The patent contains 34 claims and CPC classification C07D 401/14.
Pharmaceutical companies developing compounds targeting PPARg pathways should review this issued patent for potential freedom-to-operate considerations. Competitors active in metabolic or inflammatory disease research may need to assess whether their compound structures or methods fall within the scope of these claims.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PPARg modulators and methods of use
Grant US12606541B2 Kind: B2 Apr 21, 2026
Assignee
EISAI R&D MANAGEMENT CO., LTD.
Inventors
Sudeep Prajapati, Hyelee Lee, Stephanos Ioannidis, Kiyoyuki Omoto, Alan Rolfe, Xiang Liu, Megan Carty, Paul Dransfield, Andrew Cook
Abstract
Disclosed herein are novel compounds of Formula (1) and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing the same, and methods of using the same.
CPC Classifications
C07D 401/14
Filing Date
2021-11-08
Application No.
17521666
Claims
34
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.